Skip to content

Active Assistance for Psychological Therapy (Actissist): Using mobile technology to deliver cognitive behaviour therapy for psychosis

Active Assistance for Psychological Therapy (Actissist): Using mobile technology to deliver cognitive behaviour therapy for psychosis: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN34966555
Enrollment
36
Registered
2014-06-12
Start date
2015-03-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Mental Health

Interventions

Participants will be randomly assigned to the intervention and control groups in a ratio of 2:1, respectively (24:12). Mobile CBT: Cognitive Behavioural Therapy administered via a mobile phone. The co
a mobile phone application developed to monitor the symptoms of psychosis (Palmier-Claus et al., 2012). Follow Up Length: 10 month(s)
Study Entry : Single Randomisation only

Sponsors

University of Manchester (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. In current contact with Early Intervention Services 2. At least 4 week stabilisation of positive symptoms (score <3 on the PANSS items) 3. Mental capacity to provide informed consent 4. Sufficient English language proficiency to complete questionnaires and respond to written material 5. Aged 16 years or older

Exclusion criteria

Exclusion criteria: 1. Anyone less than 16 years old at the point of recruitment 2. Anyone incapable of giving informed consent 3. Non-English proficient 4. Score >3 on the PANSS items for positive psychotic symptoms 5. Any service user >35 years

Design outcomes

Primary

MeasureTime frame
Acceptability and feasibility; Timepoint(s): Uptake and drop-out rates will be assessed throughout. Patient feedback is taken at follow-up.

Secondary

MeasureTime frame
1. Number of social interactions, measured by the Personal and and Social Performance Scale (Morosini et al., 2000) 2. Drug use frequency, measured by the Timeline FollowBack (TLFB; Sobell & Sobell, 1992) 3. Perceived criticism, measured by the perceived criticism scale (Hooley & Teasdale, 1989) 4. Positive psychotic symptoms, measured by the Positive and Negative Syndrome Scale (PANSS; Kay,Opler & Fiszbein, 1987)

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 4, 2026